Strides Pharma Science Limited (STAR.NS)
INR 615.3
(5.29%)
INR 615.3
(5.29%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 9.16 Billion INR | -51.12% |
| 2022 | 18.74 Billion INR | 11.55% |
| 2021 | 16.8 Billion INR | 18.25% |
| 2020 | 14.21 Billion INR | 28.44% |
| 2019 | 11.06 Billion INR | -3.4% |
| 2018 | 11.45 Billion INR | 1.41% |
| 2017 | 11.29 Billion INR | -15.1% |
| 2016 | 13.3 Billion INR | 17.62% |
| 2015 | 11.31 Billion INR | 188.25% |
| 2014 | 3.92 Billion INR | 13.47% |
| 2013 | 3.45 Billion INR | -51.45% |
| 2012 | 7.12 Billion INR | -0.35% |
| 2011 | 7.14 Billion INR | 47.37% |
| 2010 | 4.84 Billion INR | 25.35% |
| 2009 | 3.86 Billion INR | 755.88% |
| 2008 | 452.06 Million INR | -80.05% |
| 2007 | 2.26 Billion INR | -9.72% |
| 2006 | 2.51 Billion INR | 32.38% |
| 2005 | 1.89 Billion INR | 38.69% |
| 2004 | 1.36 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 2.37 Billion INR | -0.42% |
| 2024 Q2 | 5.17 Billion INR | 4.23% |
| 2023 FY | 9.16 Billion INR | -51.12% |
| 2023 Q4 | 2.38 Billion INR | -49.58% |
| 2023 Q3 | 4.73 Billion INR | -2.96% |
| 2023 Q2 | 4.88 Billion INR | 11.48% |
| 2023 Q1 | 4.38 Billion INR | -10.79% |
| 2022 FY | 18.74 Billion INR | 11.55% |
| 2022 Q2 | 4.87 Billion INR | 2.06% |
| 2022 Q4 | 4.91 Billion INR | 11.29% |
| 2022 Q3 | 4.41 Billion INR | -9.5% |
| 2022 Q1 | 4.77 Billion INR | 46.09% |
| 2021 Q3 | 4.49 Billion INR | -1.07% |
| 2021 Q1 | 4.49 Billion INR | 55.98% |
| 2021 FY | 16.8 Billion INR | 18.25% |
| 2021 Q2 | 4.54 Billion INR | 1.09% |
| 2021 Q4 | 3.26 Billion INR | -27.27% |
| 2020 Q2 | 3.8 Billion INR | 0.8% |
| 2020 Q3 | 3.74 Billion INR | -1.61% |
| 2020 Q4 | 2.88 Billion INR | -23.05% |
| 2020 Q1 | 3.77 Billion INR | 120.07% |
| 2020 FY | 14.21 Billion INR | 28.44% |
| 2019 Q1 | 2.89 Billion INR | 37.93% |
| 2019 FY | 11.06 Billion INR | -3.4% |
| 2019 Q4 | 1.71 Billion INR | -48.62% |
| 2019 Q3 | 3.33 Billion INR | 7.19% |
| 2019 Q2 | 3.11 Billion INR | 7.73% |
| 2018 Q3 | 3.25 Billion INR | 0.03% |
| 2018 Q2 | 3.25 Billion INR | 14.09% |
| 2018 Q1 | 2.85 Billion INR | -13.39% |
| 2018 FY | 11.45 Billion INR | 1.41% |
| 2018 Q4 | 2.09 Billion INR | -35.55% |
| 2017 FY | 11.29 Billion INR | -15.1% |
| 2017 Q4 | 3.29 Billion INR | 4.27% |
| 2017 Q3 | 3.15 Billion INR | -27.43% |
| 2017 Q2 | 4.35 Billion INR | 12.62% |
| 2017 Q1 | 3.86 Billion INR | -3.44% |
| 2016 Q1 | 3.58 Billion INR | -3.92% |
| 2016 Q4 | 4 Billion INR | 11.98% |
| 2016 Q3 | 3.57 Billion INR | -11.4% |
| 2016 Q2 | 4.03 Billion INR | 12.42% |
| 2016 FY | 13.3 Billion INR | 17.62% |
| 2015 Q2 | 1.28 Billion INR | -46.07% |
| 2015 Q1 | 2.38 Billion INR | 152.05% |
| 2015 FY | 11.31 Billion INR | 188.25% |
| 2015 Q4 | 3.73 Billion INR | -38.74% |
| 2015 Q3 | 6.09 Billion INR | 374.46% |
| 2014 Q3 | 1.04 Billion INR | 0.75% |
| 2014 Q2 | 1.03 Billion INR | 28.9% |
| 2014 Q1 | 804.99 Million INR | 0.0% |
| 2014 FY | 3.92 Billion INR | 13.47% |
| 2014 Q4 | 944.78 Million INR | -9.63% |
| 2013 FY | 3.45 Billion INR | -51.45% |
| 2012 FY | 7.12 Billion INR | -0.35% |
| 2011 FY | 7.14 Billion INR | 47.37% |
| 2010 FY | 4.84 Billion INR | 25.35% |
| 2009 FY | 3.86 Billion INR | 755.88% |
| 2008 FY | 452.06 Million INR | -80.05% |
| 2007 FY | 2.26 Billion INR | -9.72% |
| 2006 FY | 2.51 Billion INR | 32.38% |
| 2005 FY | 1.89 Billion INR | 38.69% |
| 2004 FY | 1.36 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 42.265% |
| Hester Biosciences Limited | 908.84 Million INR | -908.131% |
| Aarti Drugs Limited | 1.16 Billion INR | -684.794% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -198.019% |
| Albert David Limited | 1.02 Billion INR | -792.884% |
| Alembic Limited | 872.45 Million INR | -950.171% |
| Alkem Laboratories Limited | 32.83 Billion INR | 72.096% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -1911.107% |
| Bajaj HealthCare Limited | 985.34 Million INR | -829.857% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -134244.575% |
| Brooks Laboratories Limited | 51.18 Million INR | -17802.11% |
| Eris Lifesciences Limited | 4.94 Billion INR | -85.361% |
| FDC Limited | 3.49 Billion INR | -161.798% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | 21.291% |
| Gufic Biosciences Limited | 1.18 Billion INR | -672.154% |
| Hikal Limited | 4.46 Billion INR | -105.258% |
| Ind-Swift Limited | 946.56 Million INR | -867.95% |
| Innova Captab Limited | 931.03 Million INR | -884.104% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -316.279% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -1989.226% |
| Jubilant Pharmova Limited | 14.45 Billion INR | 36.611% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -752.953% |
| Lupin Limited | 125.09 Billion INR | 92.676% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -5547.792% |
| Medico Remedies Limited | 59.67 Million INR | -15253.666% |
| Morepen Laboratories Limited | 1.98 Billion INR | -361.008% |
| Nectar Lifesciences Limited | 932.7 Million INR | -882.342% |
| Orchid Pharma Limited | 800.77 Million INR | -1044.185% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -205.879% |
| RPG Life Sciences Limited | 1.63 Billion INR | -460.214% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -2121.557% |
| Sigachi Industries Limited | 579.88 Million INR | -1480.015% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | -258.729% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -553.149% |
| Themis Medicare Limited | 1.12 Billion INR | -713.849% |
| Unichem Laboratories Limited | 6.72 Billion INR | -36.225% |
| Vaishali Pharma Limited | 84.02 Million INR | -10803.736% |
| Wanbury Limited | 978.96 Million INR | -835.916% |
| Windlas Biotech Limited | 1 Billion INR | -810.304% |
| ZIM Laboratories Limited | 1.01 Billion INR | -804.42% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -331.333% |
| Ipca Laboratories Limited | 18.98 Billion INR | 51.746% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 94.057% |
| Venus Remedies Limited | 1.91 Billion INR | -378.129% |
| Sakar Healthcare Limited | 204.07 Million INR | -4389.585% |
| Aurobindo Pharma Limited | 55.65 Billion INR | 83.538% |
| Divi's Laboratories Limited | 14.17 Billion INR | 35.34% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | -270.418% |
| Mankind Pharma Limited | 29.27 Billion INR | 68.7% |
| Sequent Scientific Limited | 2.9 Billion INR | -215.744% |
| Laurus Labs Limited | 11.9 Billion INR | 23.069% |
| Neuland Laboratories Limited | 2.92 Billion INR | -212.734% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 38.061% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 80.486% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 92.683% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -337.542% |
| Wockhardt Limited | 8.48 Billion INR | -8.046% |
| Bal Pharma Limited | 555.62 Million INR | -1549.005% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 90.444% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -545.586% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -15619.011% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -321.352% |
| Shilpa Medicare Limited | 3.33 Billion INR | -174.799% |
| Valiant Laboratories Limited | 138.02 Million INR | -6537.953% |
| Ajanta Pharma Limited | 30.46 Billion INR | 69.923% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -64364.223% |
| Granules India Limited | 10.31 Billion INR | 11.156% |
| Medicamen Biotech Limited | 335.16 Million INR | -2633.652% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -2550.875% |
| Piramal Enterprises Limited | 63.65 Billion INR | 85.606% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 57.23% |
| NATCO Pharma Limited | 10.05 Billion INR | 8.905% |
| Suven Life Sciences Limited | 109.75 Million INR | -8248.337% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -19750.724% |
| Indoco Remedies Limited | 12.06 Billion INR | 24.035% |
| Alpa Laboratories Limited | 127.38 Million INR | -7092.887% |
| Lasa Supergenerics Limited | 291.17 Million INR | -3046.675% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -197.787% |